Nairobi Kenya – The Pharmacy and Poisons Board (PPB) on September 8, 2025 hosted the Somali Medicines Regulatory Authority for discussions on strengthening collaboration in key priority areas. The engagement focused on the listing of health products and technologies, licensing, import control, market surveillance, and capacity building.

The delegation was received by Dr. Anthony Toroitich, Director of Corporate Services, on behalf of PPB CEO Dr. F. M. Siyoi.

PPB has been providing technical support to the Somali Medicines Regulatory Authority, underscoring the importance of regional cooperation in advancing medicines regulation.

The Somali delegation included Farah Sharawe – Director, Somalia Interim NMRA; Mukhtar Shube – Director of Public Health, Federal Ministry of Health; Anisa Hassan – Regulatory Officer, NMRA; Farhan Bashir – WHO Somalia Country Office Representative; Abdullahi Omar – Regulatory Officer, NMRA; and Shafie Ali – Communication Officer, Ministry of Health.

The post 𝐏𝐏𝐁 𝐇𝐨𝐬𝐭𝐬 𝐒𝐨𝐦𝐚𝐥𝐢 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐮𝐭𝐡𝐨𝐫𝐢𝐭𝐲 𝐟𝐨𝐫 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐓𝐚𝐥𝐤𝐬 – 8th September 2025 first appeared on Pharmacy and Poisons Board.

Nairobi, KENYA – The Pharmacy and Poisons Board (PPB) on 29th September 2025 hosted a high-level delegation from AIM Vaccine Co. Ltd, led by Chief Executive Officer Mr. Yan Zhou, and accompanied by representatives from Livelite International.

The team was received by PPB’s Director of Corporate Services, Dr. Anthony Toroitich, on behalf of the Chief Executive Officer, Dr. F. M. Siyoi. Discussions centred on key regulatory frameworks including Good Manufacturing Practices, Marketing Authorization, Post-Marketing Surveillance, and Pharmacovigilance.

AIM Vaccine Co. Ltd expressed keen interest in establishing a vaccine manufacturing plant in Kenya — a significant step towards building the country’s local vaccine production capacity.

Dr. Toroitich reaffirmed PPB’s full support in ensuring that all regulatory requirements will be met to facilitate the process.

ends

The post 𝐏𝐏𝐁 𝐇𝐨𝐬𝐭𝐬 𝐀𝐈𝐌 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐂𝐨. 𝐋𝐭𝐝 𝐃𝐞𝐥𝐞𝐠𝐚𝐭𝐢𝐨𝐧 first appeared on Pharmacy and Poisons Board.

Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) today hosted the Malawian Antimicrobial Resistance (AMR) Coordinating Committee, alongside representatives from the Kenya National Public Health Institute (KNHPI) and the East, Central and Southern Africa Health Community (ECSA-HC) on 21st August 2025.

Led by Dr. Emmanuel Tanui from KNHPI, the delegation sought to learn how Kenya’s Surveillance System for Antimicrobial Consumption (KESAC) is helping tackle the challenges of AMR. The visit focused on Kenya’s AMR surveillance and stewardship strategies, with the aim of boosting multisectoral governance, cross-country learning, and regional collaboration.

Hosting the delegation on behalf of PPB CEO Dr. F. M. Siyoi, Chief Principal Regulatory Officer Dr. Ali Arale underscored the importance of monitoring antimicrobial consumption to curb the rising threat of AMR. He welcomed regional cooperation as key to protecting public health.

The post 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐚𝐧𝐝 𝐏𝐨𝐢𝐬𝐨𝐧𝐬 𝐁𝐨𝐚𝐫𝐝 𝐇𝐨𝐬𝐭𝐬 𝐌𝐚𝐥𝐚𝐰𝐢𝐚𝐧 𝐀𝐌𝐑 𝐂𝐨𝐦𝐦𝐢𝐭𝐭𝐞𝐞 𝐭𝐨 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 first appeared on Pharmacy and Poisons Board.

Nairobi, Kenya – On Tuesday, August 12, 2025, the Pharmacy and Poisons Board (PPB) convened a meeting with key stakeholders in the pharmaceutical sector to address critical issues affecting the industry.

Chaired by PPB Chief Executive Officer, Dr. F. M. Siyoi, the meeting focused on stakeholders’ concerns, particularly regarding the Market Authorization of medical products in Kenya.

Dr. Siyoi emphasized the importance of stringent regulation to safeguard public health and called for strengthened collaboration to enhance public safety and regulatory oversight.

The meeting brought together representatives from the Kenya Association of Pharmaceutical Industry (KAPI), Kenya Pharmaceutical Distributors Association (KPDA), Medical Technology Industry Association of Kenya (MEDAK), Federation of Kenya Pharmaceutical Manufacturers (FKPM), and the Regulatory Affairs Professional Society of Kenya (RAPSK).

The post 𝐏𝐏𝐁 𝐄𝐧𝐠𝐚𝐠𝐞𝐬 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬 𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐮𝐭𝐡𝐨𝐫𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐏𝐮𝐛𝐥𝐢𝐜 𝐒𝐚𝐟𝐞𝐭𝐲 first appeared on Pharmacy and Poisons Board.

Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) Chief Executive Officer, Dr. F. M. Siyoi, today signed a Service Level Agreement (SLA) with the Kenya Revenue Authority (KRA), marking a major milestone in the government’s efforts to enhance trade facilitation and regulatory efficiency.

The agreement, finalized after a two-year collaboration involving 24 Partner Government Agencies (PGAs), aims to streamline sea cargo clearance processes, boost transparency, and promote coordinated service delivery in line with Kenya’s National Trade Facilitation Agenda and the World Trade Organization (WTO) Trade Facilitation Agreement.

The SLA sets out clear roles, timelines, and joint processes among the agencies, with a focus on improving accountability and operational efficiency at the ports.

Speaking at the signing, Dr. Siyoi welcomed the agreement, noting that the partnership will strengthen PPB’s role in ensuring access to quality, safe, and efficacious health products and technologies entering the country.

The KRA delegation was led by Ms. Winfred Kinyua, Assistant Manager, Customs and Border Control.

Ends

The post 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐚𝐧𝐝 𝐏𝐨𝐢𝐬𝐨𝐧𝐬 𝐁𝐨𝐚𝐫𝐝, 𝐊𝐑𝐀 𝐒𝐢𝐠𝐧 𝐋𝐚𝐧𝐝𝐦𝐚𝐫𝐤 𝐀𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 𝐭𝐨 𝐒𝐭𝐫𝐞𝐚𝐦𝐥𝐢𝐧𝐞 𝐒𝐞𝐚 𝐂𝐚𝐫𝐠𝐨 𝐂𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞 – 23rd July 2025  first appeared on Pharmacy and Poisons Board.

Nairobi, KENYA – Pharmacy and Poisons Board (PPB) CEO Dr. Fred M. Siyoi has called for urgent and unified regional action to combat the growing threat of illicit health products and technologies across East Africa.

Speaking at the official opening of the Operation African Star 2 workshop in Nairobi, on July 10, 2025 Dr. Siyoi warned that the surge in counterfeit, diverted, and illegally imported medicines is undermining public health, destabilizing economies, and weakening confidence in national health systems.

“The illicit trade in health products is a transnational crisis that thrives on regulatory gaps and weak coordination,” said Dr. Siyoi. “It endangers lives and cannot be tackled in isolation. We must move as one.”

Citing the success of Operation African Star 1 in June 2024—which intercepted falsified pharmaceuticals smuggled through small courier parcels—Dr. Siyoi credited enhanced intelligence-sharing and coordinated enforcement across East Africa as key to disrupting these illegal networks.

He also spotlighted Kenya’s pilot of the Pharmaceutical Authentication and Traceability Program (PATP) as a transformative step in supply chain oversight. “PATP allows regulators to track medicines from production to patient, detect counterfeits in real time, and take rapid enforcement or recall action,” he said.

“Operation African Star 2 reaffirms our shared commitment to protecting the public from harmful products and ensuring access to safe, quality-assured health products and technologies,” Dr. Siyoi added. “We are embracing digitization, including AI-powered tools, to fast-track a robust track and trace system that enhances supply chain integrity across the region.”

Aligned with global standards, the initiative is designed to increase transparency, bolster regulatory vigilance, and protect patients. Dr. Siyoi emphasized that success depends on strong collaboration among regulators, logistics providers, ICT partners, manufacturers, and end users.

The multi-agency workshop brings together a range of stakeholders, including Uganda’s National Drug Authority, USAID-OIG, the National Association of Boards of Pharmacy (NABP), the International Narcotics Control Board (INCB), GS1, Novartis, and others.

Calling on delegates to deepen regional collaboration, Dr. Siyoi urged joint field exercises, shared data platforms, and harmonized regulatory frameworks to address the evolving threats. “Let us protect lives, restore trust, and take decisive action in the fight against illicit medicines,” he said.

The two day workshop, focuses on practical, cross-border strategies to secure pharmaceutical supply chains and safeguard consumers across East Africa.

ends

The post 𝐄𝐚𝐬𝐭 𝐀𝐟𝐫𝐢𝐜𝐚 𝐈𝐧𝐭𝐞𝐧𝐬𝐢𝐟𝐢𝐞𝐬 𝐄𝐟𝐟𝐨𝐫𝐭𝐬 𝐀𝐠𝐚𝐢𝐧𝐬𝐭 𝐈𝐥𝐥𝐢𝐜𝐢𝐭 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐚𝐬 𝐏𝐏𝐁 𝐂𝐄𝐎 𝐂𝐚𝐥𝐥𝐬 𝐟𝐨𝐫 𝐒𝐭𝐫𝐨𝐧𝐠𝐞𝐫 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧 first appeared on Pharmacy and Poisons Board.

Nairobi, KENYA – The Pharmacy and Poisons Board (PPB), in partnership with PATH, on Thursday 3rd July 2025 conducted a Good Manufacturing Practices (GMP) training for local pharmaceutical manufacturers as part of ongoing efforts to enhance regulatory standards in Kenya.

The training comes at a critical time as the country works toward attaining World Health Organisation (WHO) Maturity Level 3, a key milestone in regulatory capacity.

The session was officiated by Dr. Antony Toroitich, Director of Corporate Services, who represented the Chief Executive Officer, Dr. F. M. Siyoi. In his remarks, Dr. Toroitich underscored the need to address gaps identified during GMP inspections and to support the growth of a robust local pharmaceutical manufacturing sector.

He reaffirmed PPB’s commitment to safeguarding public health by ensuring that all health products and technologies (HPTs) manufactured locally meet the highest standards of safety, quality, and efficacy through sustained capacity building and strategic partnerships.

Ends…

The post 𝐏𝐏𝐁 𝐚𝐧𝐝 𝐏𝐀𝐓𝐇 𝐂𝐨𝐧𝐝𝐮𝐜𝐭 𝐆𝐌𝐏 𝐓𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐭𝐨 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐋𝐨𝐜𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 first appeared on Pharmacy and Poisons Board.

The meeting, chaired by Dr. Ahmed Mohamed, Director of Health Products and Technologies, on behalf of PPB CEO Dr. F. M. Siyoi, focused on enhancing regulatory capacity and exploring opportunities for technical collaboration between the two countries.

Key areas of discussion included capacity building in regulatory functions such as product registration, vaccine lot release, and inspectorate operations; technology transfer to support local vaccine manufacturing; and the potential for mutual agreements with India’s Central Drugs Standard Control Organization and the Indian Pharmacopoeia.

The engagement aimed to deepen Kenya–India collaboration in support of a robust and self-reliant pharmaceutical sector in Kenya.

The post 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐚𝐧𝐝 𝐏𝐨𝐢𝐬𝐨𝐧𝐬 𝐁𝐨𝐚𝐫𝐝 𝐄𝐱𝐩𝐥𝐨𝐫𝐞𝐬 𝐃𝐞𝐞𝐩𝐞𝐫 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐈𝐧𝐝𝐢𝐚 first appeared on Pharmacy and Poisons Board.

Mombasa, Kenya: The regulatory session at the 45th Annual Scientific Conference of the Pharmaceutical Society of Kenya (PSK), held on June 20, 2025, provided a dynamic platform for discussion on strengthening pharmaceutical regulation in Kenya. Chaired by Dr. F. M. Siyoi, Chief Executive Officer of the Pharmacy and Poisons Board (PPB), the session highlighted key regulatory developments and ongoing reforms.

In his opening remarks, PPB Chairman Dr. Charles Githinji reaffirmed the Board’s firm commitment to supporting pharmacists across all practice areas. “We are focused. We are listening. And I assure you—your concerns will be addressed through strong, responsive, and technically grounded leadership to make pharmacy thrive,” he stated.

Dr. Githinji emphasized several priorities driving the Board’s agenda, including enforcement of Good Pharmacy Practices, proper scheduling and classification of medicines, and active engagement with the Health Products and Technologies (HPTs) Bill currently before the Senate. “We are monitoring its progress to ensure that the voice of the pharmacy profession is reflected. Regulation is a core mandate of government, and I am personally committed to ensuring full implementation of the commitments we make,” he added.

The session featured strong participation from key PPB directorates—Health Products and Technologies, Corporate Services, and Pharmacy Practice—who outlined ongoing regulatory progress. Dr. Siyoi reiterated the Board’s dedication to elevating regulatory standards nationwide and noted that PPB is at an advanced stage in its pursuit of World Health Organization (WHO) Maturity Level 3 status.

Panel discussions, spotlighted priority actions underway to enhance service delivery and patient safety. These include proactive post-marketing surveillance, capacity-building in pharmacovigilance, initiation of bioequivalence studies, and development of regulatory frameworks to support specialization in pharmacy practice.

The session reinforced PPB’s position as a technically competent, stakeholder-driven institution committed to securing a safe, responsive, and accountable pharmaceutical sector.

Ends 

The post Pharmacy and Poisons Board Advances Regulatory Priorities at 45th PSK Scientific Conference first appeared on Pharmacy and Poisons Board.

Mombasa, Kenya: Health CS Hon. Aden Duale has emphasized that digitizing Kenya’s pharmaceutical sector is essential to eliminate counterfeits, boost transparency, and improve service delivery.

Addressing the 45th Annual PSK Conference in Mombasa on June 18, 2025, the CS urged pharmacists to embrace the Digital Health Superhighway, which features e-prescriptions, digital dispensing, real-time drug monitoring, and pharmacy integration into the national system.

He confirmed the transition to fully digital records and commended Mombasa County’s leadership in digital health. Hon. Duale reiterated the government’s commitment to local manufacturing, strong regulation, and digital-led pharmacovigilance.

“Digitization is how we protect patients and restore trust in the pharmaceutical sector,” he stated.

Ends 

The post 𝐃𝐮𝐚𝐥𝐞: 𝐃𝐢𝐠𝐢𝐭𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐂𝐫𝐮𝐜𝐢𝐚𝐥 𝐟𝐨𝐫 𝐒𝐚𝐟𝐞 𝐚𝐧𝐝 𝐀𝐜𝐜𝐨𝐮𝐧𝐭𝐚𝐛𝐥𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐒𝐞𝐜𝐭𝐨𝐫 first appeared on Pharmacy and Poisons Board.